CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 4,281,094	$ 167,725
Trade receivables, net of allowance of $26,000 and $45,833, respectively	3,971	5,539
Inventories, net	615,674	534,431
Prepaid and other current assets	189,730	71,575
Total current assets	5,090,469	779,270
Property, Plant and Equipment:	24,148,192	24,867,176
Accumulated depreciation	(23,964,362)	(24,848,408)
Property, Plant and Equipment, net	183,830	18,768
Other Assets:
Operating lease right-of-use assets, net	5,150,718	5,633,663
Patents, net of accumulated amortization of $495,745 and $467,102, respectively	393,545	439,836
Other non-current assets	625,000	500,000
Total Assets	11,443,562	7,371,537
Current Liabilities:
Accounts payable	650,720	736,986
Related party payables	45,000	135,834
Accrued expenses	1,031,017	1,518,212
Accrued interest	479,872	438,063
Notes payable	250,000	250,000
Current portion of operating lease liability	628,438	575,404
Promissory notes, net		193,200
Convertible notes, net	250,000
Embedded derivative liability		5,303,984
Total current liabilities	3,335,047	9,151,683
Long-Term Liabilities:
Non-current operating lease liabilities	4,698,431	5,179,229
Non-current secured promissory notes, net		5,405,637
Non-current convertible notes, net	8,006,452	7,813,048
Accrued warranty liability	21,225	14,143
Total liabilities	16,061,155	27,563,740
Stockholders’ Deficit:
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($789,241 and $752,765 Liquidation Preference, respectively)	5	5
Common stock, $0.0001 par value, 30,000,000,000 authorized; 19,678,916,809 and 18,102,583,473 shares issued and outstanding, respectively	1,967,891	1,810,258
Additional paid in capital	417,608,765	399,780,319
Accumulated deficit	(424,194,254)	(421,782,785)
Total stockholders’ deficit	(4,617,593)	(20,192,203)
Total Liabilities and Stockholders’ Deficit	$ 11,443,562	$ 7,371,537